Back to JF Jump Financial, LLC

SLNSLN

Showing 2 of 5 quarters

Position history for JFJump Financial, LLC's holdings in Silence Therapeutics Plc

No. Jump Financial exited its SLN (Silence Therapeutics) position in Q2 2025. Its Q1 2025 13F listed 26,351 shares worth $74,310. Jump Financial first reported SLN in Q1 2024 and held it in 3 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$74,310

Total Shares Change

-26,351

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$5.80
0
2025-Q1
New
26,351
—
$74,3100.0%$2.82
29

Optional analytics helps us improve. How it’s used